Literature DB >> 18446423

Seroprevalence distribution of Aichi virus among a French population in 2006-2007.

Marianne Goyer1, Ludwig-Serge Aho, Jean-Baptiste Bour, Katia Ambert-Balay, Pierre Pothier.   

Abstract

Little is known about the epidemiology of Aichi virus, which is a new member of the family Picornaviridae, in the genus Kobuvirus. We report here on seroprevalence in France. Sera were screened using an enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G. Of 972 sera tested, seroprevalence ranged from 25% for the 7-month-to-9-year-old age group to about 85% for the 30-to-39-year-old age group and older age groups. Our ELISA correlated well with the microneutralization technique. This study shows that Aichi virus is quite frequent in France and that seroconversion occurs before the age of 40.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446423     DOI: 10.1007/s00705-008-0091-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  Molecular detection and characterization of Aichi viruses in sewage-polluted waters of Venezuela.

Authors:  Ana Alcalá; Esmeralda Vizzi; Jesús Rodríguez-Díaz; José L Zambrano; Walter Betancourt; Ferdinando Liprandi
Journal:  Appl Environ Microbiol       Date:  2010-04-23       Impact factor: 4.792

2.  Seroprevalence of Aichi virus in a Spanish population from 2007 to 2008.

Authors:  Juan Manuel Ribes; Rebeca Montava; Carlos J Téllez-Castillo; Manuel Fernández-Jiménez; Javier Buesa
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

3.  A novel picornavirus associated with gastroenteritis.

Authors:  Linlin Li; Joseph Victoria; Amit Kapoor; Olga Blinkova; Chunlin Wang; Farbod Babrzadeh; Carl J Mason; Prativa Pandey; Hinda Triki; Olfa Bahri; Bamidele Soji Oderinde; Marycelin Mandu Baba; David Nadeba Bukbuk; John M Besser; Joanne M Bartkus; Eric L Delwart
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

4.  High variety of known and new RNA and DNA viruses of diverse origins in untreated sewage.

Authors:  Terry Fei Fan Ng; Rachel Marine; Chunlin Wang; Peter Simmonds; Beatrix Kapusinszky; Ladaporn Bodhidatta; Bamidele Soji Oderinde; K Eric Wommack; Eric Delwart
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

5.  Development of a reverse transcription-quantitative PCR system for detection and genotyping of aichi viruses in clinical and environmental samples.

Authors:  Masaaki Kitajima; Akihiko Hata; Teruo Yamashita; Eiji Haramoto; Hiroko Minagawa; Hiroyuki Katayama
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

6.  Aichi virus IgG seroprevalence in Tunisia parallels genomic detection and clinical presentation in children with gastroenteritis.

Authors:  Khira Sdiri-Loulizi; Mouna Hassine; Jean-Baptiste Bour; Katia Ambert-Balay; Maha Mastouri; Ludwig-Serge Aho; Hakima Gharbi-Khelifi; Zaidoun Aouni; Nabil Sakly; Slaheddine Chouchane; Mohamed Neji-Guédiche; Pierre Pothier; Mahjoub Aouni
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

7.  A complex comprising phosphatidylinositol 4-kinase IIIβ, ACBD3, and Aichi virus proteins enhances phosphatidylinositol 4-phosphate synthesis and is critical for formation of the viral replication complex.

Authors:  Kumiko Ishikawa-Sasaki; Jun Sasaki; Koki Taniguchi
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

8.  ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites.

Authors:  Jun Sasaki; Kumiko Ishikawa; Minetaro Arita; Koki Taniguchi
Journal:  EMBO J       Date:  2011-11-29       Impact factor: 11.598

9.  Molecular detection of novel astroviruses in wild and laboratory mice.

Authors:  Tibor Farkas; Brittney Fey; Gary Keller; Vito Martella; Laszlo Egyed
Journal:  Virus Genes       Date:  2012-08-17       Impact factor: 2.332

10.  Aqueous Extracts of Hibiscus sabdariffa Calyces to Control Aichi Virus.

Authors:  Doris H D'Souza; Lezlee Dice; P Michael Davidson
Journal:  Food Environ Virol       Date:  2016-02-18       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.